{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:55:10Z","timestamp":1771048510155,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1093\/jac\/dkq164","type":"journal-article","created":{"date-parts":[[2010,5,23]],"date-time":"2010-05-23T00:34:00Z","timestamp":1274574840000},"page":"1448-1454","source":"Crossref","is-referenced-by-count":25,"title":["CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis"],"prefix":"10.1093","volume":"65","author":[{"given":"Shraddha A.","family":"Sane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,5,22]]},"reference":[{"key":"key\n\t\t\t\t20170425171800_DKQ164C1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C2","first-page":"345","article-title":"Visceral leishmaniasis\u2014current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C4","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphocholines and related derivates against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdon","year":"2008","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000062171","article-title":"CpG oligodeoxynucleotides","volume-title":"New Drugs for Asthma, Allergy and COPD: 31 (Progress in Respiratory Research)","author":"Kline","year":"2001"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1215\/S1522851705000475","article-title":"Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma","volume":"8","author":"Carpentier","year":"2006","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"Vollmer","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1521-6616(03)00202-X","article-title":"Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates","volume":"109","author":"Verthelyi","year":"2003","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/eji.200323671","article-title":"Targeting of immunostimulatory DNA cure experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation","volume":"33","author":"Datta","year":"2003","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/CVI.00413-07","article-title":"Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB\/c mice","volume":"15","author":"Badiee","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","article-title":"Efficacy of picroliv combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis","volume":"94","author":"Gupta","year":"2005","journal-title":"Acta Tropica"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C17","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2007.05.009","article-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome","volume":"25","author":"Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nbt1184-979","article-title":"Dehydration\u2013rehydration vesicles: a simple method for high yield drug entrapment in liposomes","volume":"2","author":"Kirby","year":"1984","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C19","first-page":"439","article-title":"Exploration of antileishmanial activity in heterocycles; results of their in vivo & in vitro bioevaluations","volume":"89","author":"Bhatnagar","year":"1989","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(03)00086-X","article-title":"Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes","volume":"331","author":"Walrand","year":"2003","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1189\/jlb.0903415","article-title":"Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide","volume":"75","author":"Sharma","year":"2004","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0031182003003457","article-title":"Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis","volume":"127","author":"Shrivastava","year":"2003","journal-title":"Parasitology"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C23","volume-title":"Probit Analysis","author":"Finney","year":"1971","edition":"3rd edn"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C24","first-page":"101","article-title":"Survival of intracellular pathogens within human mononuclear phagocytes","volume":"25","author":"Murray","year":"1988","journal-title":"Semin Hematol"},{"key":"key\n\t\t\t\t20170425171800_DKQ164C25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/infdis\/173.3.758","article-title":"A cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis","volume":"173","author":"Badaro","year":"1994","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/7\/1448\/13762159\/dkq164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T16:26:29Z","timestamp":1503505589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkq164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,22]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,5,22]]},"published-print":{"date-parts":[[2010,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkq164","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,22]]}}}